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Abstract
The extracellular environment of vascular cells in vivo is complex in its chemical composition, physical properties, and architec-
ture. Consequently, it has been a great challenge to study vascular cell responses in vitro, either to understand their interaction with
their native environment or to investigate their interaction with artificial structures such as implant surfaces. New procedures and
techniques from materials science to fabricate bio-scaffolds and surfaces have enabled novel studies of vascular cell responses
under well-defined, controllable culture conditions. These advancements are paving the way for a deeper understanding of vascular
cell biology and materials–cell interaction. Here, we review previous work focusing on the interaction of vascular smooth muscle
cells (SMCs) and endothelial cells (ECs) with materials having micro- and nanostructured surfaces. We summarize fabrication tech-
niques for surface topographies, materials, geometries, biochemical functionalization, and mechanical properties of such materials.
Furthermore, various studies on vascular cell behavior and their biological responses to micro- and nanostructured surfaces are
reviewed. Emphasis is given to studies of cell morphology and motility, cell proliferation, the cytoskeleton and cell-matrix adhe-
sions, and signal transduction pathways of vascular cells. We finalize with a short outlook on potential interesting future studies.
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Figure 1: Schematic illustration of cell interaction with a micro- and nanostructured biofunctionalized surface and the two relevant size scales. The
surface is structured with a micropattern, e.g., grooves or pits at the size of micrometers or below, corresponding to the size of cells. On a much
smaller size scale, adhesive receptors interact with small surface features in the nanometer range. This interaction is schematically illustrated by
nanoparticles that are functionalized with adhesive peptides. Cells interact with their extracellular environment by binding to cell adhesion-mediating
molecules with their cell adhesion protein machinery. The surface topography and other characteristics such as the mechanical stiffness may lead to
different availability of cell adhesion-mediating molecules and also require a deformation of cellular structures such as the cytoskeleton, adhesion
sites or the membrane. All these interactions may transmit extracellular signals further into the cell yielding in a biological cell response. Typical exam-
ples might be changes in cell alignment, elongation, migration direction and gene expression.
Introduction
Cells adhering to biomaterials are influenced by the surface to-
pography, the surface chemistry and the mechanical properties
of the substrate (Figure 1). In particular, the influence of the
surface topography on cell behavior has been widely studied,
with the motivation to understand the complex cell–substrate
interactions and to transfer that knowledge to the design of
implant surfaces. This review summarizes and discusses model
studies with a special emphasis on the fabrication of substrates
with well-defined nano- and microstructured surfaces for in
vitro studies with vascular cells (Figure 1). Vascular endotheli-
al cells (ECs) and smooth muscle cells (SMCs) are two vascular
cell types forming blood vessels (Figure 2). They are key
players in cardiovascular diseases and are the cells getting in
immediate contact with many cardio-vascular medical devices
such as stents. The integrity of the endothelia cell layer is essen-
tial for avoiding thrombosis. The detailed understanding of the
responses of ECs and SMCs to different physical and chemical
properties of an adhesive surface may lead to a better under-
standing of their biology and the origin of vascular diseases and
malfunctions. Additionally, such knowledge will be supportive
for the adequate and successful design and development of
medical implants, e.g., stents. Thus, in vitro studies using modi-
fied artificial surfaces to induce biological responses in these
cells are an important experimental model in vascular cell
biology and biomaterial research (Figure 3).
In this review, we provide an overview of materials and impor-
tant micro- and nanofabrication techniques that have been used
for the fabrication of appropriate substrates for in vitro studies
with vascular cells. We give a brief overview over possible sur-
face structure geometries, mention compounds and methods for
surface biofunctionalization and present the importance of the
mechanical characteristics of cell-study relevant micro/nano-
structured surfaces. In the last section of this review, we eval-
uate and summarize reports about studies of vascular cells inter-
action with micro/nanostructured surfaces.
Review
1 Fabrication of micro- and nanopatterned
substrates for cell biology studies
The development of micro- and nanofabrication techniques has
permitted the manufacturing of precise surface topographies of
materials surfaces. Samples with specific surface features haven
been widely used for in vitro cell biology studies either to
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Figure 2: (A) Scheme of a blood vessel. Vascular endothelial cells
(EC) form the inner dense cell layer of the blood vessel (endothelium)
and are in direct contact with the blood. Vascular smooth muscle cells
(SMC) build up a thicker outer layer surrounding the inner endothe-
lium. SMCs are embedded within the extracellular matrix (ECM).
(B,C) Morphology of (B) vascular ECs and (C) vascular SMCs cultured
on fibronectin-coated, microstructured silicon-based polymeric sub-
strates with 3 µm wide and 200 nm deep grooves (phase-contrast
images, scale bar: 200 µm. Double white arrows indicate microgrooves
direction).
manipulate cell adhesion and resulting cell responses or to give
surfaces sensor capabilities [2-11]. The topographies either
mimic typical shapes and feature sizes found in the natural envi-
ronment of cells or expose them to rather artificial often well-
ordered geometries. Considering the length scales of interac-
tion, either on the molecular size of adhesion proteins and their
ligands, or on the size of cells, the effective structuring of sur-
faces with nanometer to micrometer precision is required. In
this section, we review the currently available most common
techniques and materials applied for the fabrication of appro-
priate micro/nanotopographies. We define micro/nanostruc-
tured substrates as materials having fabricated surface struc-
tures in all three dimensions and, consequently, not having a
planar surface.
The number of possible architectures of micro/nanostructured
substrates is huge and it is often difficult to keep track with all
varieties. However, common architectures are pores, gratings,
wells, pits, cones, posts, pillars, grooves (Figure 4A) or mesh-
like structures that can either be organized in a regular or irreg-
ular manner. For a systematic overview of the information
presented in this section and about the fabrication techniques
and the selection of materials for micro/nanostructured sub-
strates as well as common geometries please refer to Table 1.
1.1 Fabrication methods
In order to create tailored cell culture substrates with surface
topographies established methods such as photolithography,
electron- and focused-ion beam lithography, stereolithography,
direct laser writing, and block co-polymer micellar nanolithog-
raphy are applied. Based on the fabrication approach, fabrica-
tion techniques can be divided whether they follow a top-down
approach or a bottom-up approach. In the first approach, an
already existing bulk material is structured while in the latter
approach single subunits are used to build up a structured sub-
strate (e.g., by layer-by-layer technique). Depending on the
pattern design procedure, fabrication techniques can be distin-
guished in either computer-assisted methods or methods with-
out the aid of computers, such as methods using the self-organi-
zation of macromolecular systems. Computer-assisted methods,
also known as solid free-form or rapid prototyping, initally
require the design of a computer model with a special software.
The second step is then the realization of the computer model
with a specific fabrication system that can be grouped in either
laser-based system, 3D printing setups, and nozzle-based
settings [46-48].
We group these fabrication techniques by the size and spatial
resolution of the surface features that can be achieved. Not
every method is suitable for the production of desired surface
feature size. In particular, some methods are not suited for
structuring surface topographies in the nanometer range.
1.2 Microfabrication techniques
Microfabrication techniques are mainly used to generate sur-
face structures in the micrometer range, which is the size scale
Beilstein J. Nanotechnol. 2016, 7, 1620–1641.
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Figure 3: Materials science provides tools to create surface topographies with different geometries and sizes ranging from the nanoscale to the
microscale. These topographies mimic in vivo environments in order to study biological processes and to develop new medical implants that are able
to control cell behavior in vivo. Research of the reactions to vascular cells to surface topographies will enable the development of micro/nanostruc-
tured stents in order to improve wound healing and to control cell proliferation, thus avoiding the re-occlusion of the blood vessel (restenosis). The
image of the human body, as well as the cross-sectional view of a stent inside a blood vessel have both been adapted from the Powerpoint Image
Bank of the Servier Medical Art collection [1] under the CC BY 3.0 licence, copyright 2016 Les Laboratoires Servier.
of cells. In order to give an overview of different microfabrica-
tion techniques, relevant examples for different approaches such
as optical (photolithography [49]), mechanical (hot embossing
[50] and surface cracking [51,52]) or chemical (replica molding
[53,54], phase separation micromolding [55-57], gas-based
techniques [55-57] and porogen-leaching methods [55]) are de-
scribed. They often rely on the fabrication of a master with a
designed surface topography that subsequently is replicated by a
polymer. Most of these techniques have been extensively used
and have allowed for novel types of experiments in cell biology
for the last two decades [53,54].
Photolithography uses light, a photomask and a photosensitive
material (photoresist) to create a pattern in the micrometer (or
sub-micrometer) range (Figure 4B). The thickness of the layer
of photoresist will determine the height of the structures. The
Beilstein J. Nanotechnol. 2016, 7, 1620–1641.
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Figure 4: (A) The microgrooved PDMS replica is properly characterized through atomic force microscopy (AFM) and scanning electron microscopy
(SEM) to confirm the dimensions of the groove structure are identical to the master structure. Subsequently the microgroved PDMS structure can be
homogenously (or selectively) functionalized with cell adhesion-mediating biomolecules (such as the extracellular matrix protein fibronectin). (B) Flow
chart of the fabrication of microgroove structured poly(dimethylsiloxane) (PDMS) substrates following the principles of soft lithography. A sandwich
made of chrome mask, photoresist, and silicon wafer is illuminated by UV light to induce photo-resist polymerization. The polymerized photoresist
forms structures on the silicon wafer as a master structure for the PDMS replica. The PDMS is molded on the master structure and is peeled off after
polymerization resulting in a PDMS replicate with microgrooved structures. (C) Vascular cells are cultured on the bio-functionalized microgrooved
PDMS substrates. The direction of the grooves is indicated by the black arrows. The F-actin cytoskeleton (green), the cell nucleus (blue) and the
cell–matrix adhesion sites (paxillin; red) can be visualized by immunochemistry or staining with specific dyes through fluorescence microscopy.
Table 1: Overview of in vitro studies of vascular cell responses to micro/nanostructured surface features. Various materials, fabrications methods and
geometries (dimensions) are employed and different biological readouts using vascular smooth muscle cells (SMCs) and/or vascular endothelial cells
(ECs) are supplied.
geometry feature sizea material fabrication method cell type biological response ref.





cell orientation and migration
along grooves; enhanced cell
elongation
[12]






cell body, actin and focal
adhesion orientation along
grooves; proliferation is not
influenced
[13]
grooves d = 10 µmw = 30 µm PDMS
photolithography;
soft lithography ECs
cell body, actin and focal
adhesion orientation along
grooves; changes in gene
expression
[14]
grooves d < 1 µmw < 1 µm PDMS surface cracking SMCs
increased focal adhesion size
along grooves [15]





increased cell and nucleus
elongation; cell body and actin




d = 1.5 or 5 µm







ECs cell body and nucleusorientation along grooves [17]





ECs cell alignment along grooves;decreased circularity [18]
grooves d = 0.1–1 µmw = 1 µm COC
e nano-imprint
lithography ECs
enhanced cell adhesion on
shallow grooves; variations in
focal adhesion composition on
different grooves
[19]
grooves d = 0.1–2 µmw = 1–5 µm COC
nano-imprint
lithography ECs
early onset of cell spreading
induced by grooves [20]
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Table 1: Overview of in vitro studies of vascular cell responses to micro/nanostructured surface features. Various materials, fabrications methods and
geometries (dimensions) are employed and different biological readouts using vascular smooth muscle cells (SMCs) and/or vascular endothelial cells
(ECs) are supplied. (continued)
grooves d ≈ 200 nmw = 750 nm to 100 µm Ti
photolithography;
plasma dry etching ECs
cell alignment along grooves;
increased cell elongation;
higher cell density (on grooves
with w < 10 µm)
[16]
grooves
d = 11 µm
w(groove) = 20–60 µm
w(ridge) = 10 µm
PDMS plasma etching;soft lithography SMCs
increased alignment of cell
body, actin fibers and nucleus
on narrow grooves
[21]
grooves d = 2.8 µmw = 10 µm PDMS
photolithography;
soft lithography SMCs
enhanced cell elongation and
orientation along grooves;





d = 500 nm











elongation and increased cell
density on nanorough areas
[23]




ratio and cell alignment; ECM
remodeling
[24]
grooves w = 350, 700, 1050 nmd: 500 nm PLGA
f thermal imprinting ECs
enhanced adhesion strength;




w(ridge) = 600 nm
w(groove) = 1200 nm
d = 600 nm
PDMS photolithography;soft lithography ECs
increased cell elongation,




ripples h = 25–100 nm PETg UV lithography ECs nuclear β-catenin accumulation(proliferative phenotype) [27]
ripples
w = 620 nm
d = 100 nm
h = 15–600 nm
nitinol laser lithography ECs increased cell orientation alongthe structures [28]
convex
hemi-spheres
 = 190–950 nm
h: 5–396 nm
spacing = 195–957 nm
PLGA soft lithography ECs increased cell adhesion [29]
pores d = 20 nm, d = 200 nm aluminamembranes
commercially
available SMCs
enhanced cell proliferation and
gene expression (on 200 nm
pits)
[30]
tubes l = 1 µm = 30 nm TiO2 anodization
ECs,
SMCs




tubes  = 15–100 nm TiO2 anodization ECs
increased cell adhesion,
proliferation and motility (on
nanotubes with  = 15 nm)
[32]











increased expression of SMC
α-actin
[31]








decreased cell adhesion and
spreading (on SiO2 pillars with
h > 3 µm); enhanced cell
alignment and elongation (on
PDMS pillars)
[34]
pyramids h = 50–1850 nm Si wet chemicaletching ECs
reduced cell migration;
decreased adhesion [35]
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Table 1: Overview of in vitro studies of vascular cell responses to micro/nanostructured surface features. Various materials, fabrications methods and
geometries (dimensions) are employed and different biological readouts using vascular smooth muscle cells (SMCs) and/or vascular endothelial cells
(ECs) are supplied. (continued)
cones
 = 50 nm (at tip)
h = 300–500 nm
spacing: 150 nm
PEG-DMAh Soft lithography ECs Increased cell adhesion [36]
cones
 = 0.15 µm (at tip)
h: 10 µm
spacing: 6 µm
Silicon Laser surfacetexturing ECs
Increased cell spreading and
adhesion [37]
hills/bulges h = 13–95 nm PS/PBrSi polymer demixing,spin coating ECs
increased cell adhesion and




h = 27 nm
 = 223 nm
spacing = 1638 nm
PCLj/PEG polymer demixing,spin coating ECs
reduced cell adhesion and
spreading [39]
hills/bulges h = 13–95 nm PS/PBrS,PnBMAk/PS
polymer demixing,
spin coating ECs
increased cell adhesion (on
islands with h = 13 and 18 nm) [40]





increased cell adhesion and
proliferation [41,42]
random nanoroughness, = 7–21 nm SiO2 coating ECs
decreased cell adhesion,
spreading and proliferation [43]
random mesh composed of fiberswith  = 13 µm PGA
m surface hydrolysis SMCs increased cell adhesion andproliferation [44]
random
surface roughness in the
sub-micrometer to
nanometer range
PU, PLGA chemical etching SMCs increased adhesion andproliferation [41,42]
random nanoroughness, about11 nm PCL hot pressing
SMCs,
ECs
increased cell adhesion and
proliferation [45]
ad: depth; h: height; w: width; : diameter; l: length; bPDMS: poly(dimethylsiloxane); cPMMA: poly(methyl methacrylate); dPGS: poly(glycerol seba-
cate); eCOC: cyclic olefin copolymer; fPLGA: poly(lactic-co-glycolic acid); gPET: poly(ethylene terephthalate); hPEG-DMA: poly(ethylene glycol)
dimethacrylate; iPS/PBrS = polystyrene/poly(4-bromostyrene); jPCL: poly(caprolactone); kPnBMA: poly(n-butyl methacrylate); lPU = poly(ether
urethane); mPGA: poly(glycolic acid).
pattern of the photomask will determine the later dimensions
of a surface structure [49]. This method can be combined
with other procedures such as physical or chemical vapor
deposition where the height of the pattern can be further con-
trolled by depositing a nanometrically controlled layer, often
using metals [58]. The surface structures made by photolithog-
raphy are typically further used as a master structure for further
processing.
Hot embossing also replicates micro- and nanofeatures of
master substrates. In that case, a thermoplastic material is
pressed on the mold at a high temperature to form the topogra-
phy of the features in the plastic. Similar to replica molding in
soft lithography, features down to around 10 nm can be repli-
cated. Like soft lithography hot embossing is a cheap method
suitable for large-scale manufacturing of substrates [50]. In
principle, it can be used with many thermoplastic polymers.
Another method for generating surface topographies is surface
cracking. It provokes controlled cracks on a surface of a materi-
al and surface microstructures but also nanotopographies can be
obtained by this method [51,52]. After surface modification
(e.g., plasma treatment) of an elastomer like poly(dimethyl-
siloxane) (PDMS) strain can be applied on the substrate. Due to
the rigidity and fragility of the layer formed on the top of the
elastic PDMS substrate, an array of parallel cracks perpendicu-
lar to the strain direction will be formed. Depending on the
strain, its direction, and its amplitude, cracks with different
shapes can be formed. These cracks are typically few hundreds
of nanometers deep and between ca. 100 nm and ca. 3 µm wide.
One advantage of this technique is the possibility to change in
situ the size of the cracks by modifying the strain, enabling the
study of cell adaptation to dynamic changes of the substrate
topography [51,52].
Replica molding is a soft lithography technique that uses an
elastomeric soft material to replicate patterns (Figure 4B)
[53,54]. With that method mainly micrometer-sized topogra-
phies are produced in the elastomer. Structures with high aspect
ratios (height/lateral distance) are not easy to replicate with this
method. Due to the relative simple procedure, soft lithography
and related methods have been widely used in cell biology
studies and are widely established as a standard tool [53,59-61].
The soft material is poured onto the surface with the desired
Beilstein J. Nanotechnol. 2016, 7, 1620–1641.
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pattern and let to polymerize. After polymerization, the replica
is peeled off from the mold (Figure 4B). The lower limit of
replica topographies will depend on the material used to repli-
cate. With (PDMS), a commonly used elastomer, it was
possible to replicate nanostructures of few tens of nanometers,
for example (Figure 4B) [53] After further modifications, the
elastomer substrate can be used for cell experiments.
Phase separation micromolding is an alternative, less common
microfabrication technique for structured substrates. This tech-
nique consists of separating a polymer solution in two phases,
typically by means of the addition of a non-solvent or a change
in temperature. The phase containing the major concentration of
the polymer solidifies forming the replicate of the surface
topography [2,55,62].
Gas-based techniques [55-57,63] and porogen-leaching methods
[55] process polymeric material and are also applied to fabri-
cate cell culture substrates. However, the substrates resulting
from these fabrication methods are in most cases (irregularly)
porous, foam-like 3D structures rather than (symmetrical) sur-
face-patterned substrates.
1.3 Nanofabrication techniques
Nanofabrication techniques are mainly used to generate surface
structures in the nanometer range. Similar to the previous
section, relevant examples of nanofabrication techniques using
different approaches, such as optical (nanometer-scale optical
photolithography [49,58,64,65], nanoimprint lithography [66]),
etching (focused-ion beam [67] and electron-beam nanolithog-
raphy [68]), electrical (electrospinning [69-72]), mechanical
(nanoskiving [46,73], nanoimprint lithography [66]) and
colloidal (colloidal lithgraphy [74,75]) are given here.
Nanoscale optical photolithography takes advantage of optical
superresolution, with which it is possible to go below the light
diffraction limit, to perform photolithography with nanometer
resolution. For example, using nano-antennas it was possible,
by two-photon polymerization, to produce photoresist nanodots
with diameters below 30 nm [64]. In a different work, a
plasmon was used to pattern a photoresist layer by means of
NSOM (near-field scanning optical microscopy). A lateral reso-
lution of about 50 nm was achieved, with a fabrication speed of
ca 10 mm/s [65].
Nanoimprint lithography (NIL) is a low-cost nanopatterning
technique for 2D and 3D structures, consisting on transferring a
pattern from a mold to a surface [66]. This technique that can be
carried out in three different ways: heating, ultra-violet curing
(UV-NIL) and micro contact imprint. However, UV-NIL has
the advantage to achieve higher resolutions than the other
two techniques [76]. In UV-NIL, the mold is brought
into contact with a wafer previously coated with photoresist
and solidified with UV light. A resolution of 30 nm can be
achieved [77].
Focused-ion beam nanolithography relies on a beam of ions to
locally modify a surface coating, to mill a substrate or to deposit
materials [67]. The resolution in milling surfaces is around
5–10 nm. One advantage of this technique over other tech-
niques is that it can mill structures with irregular geometries and
it requires few processing steps. One disadvantage is the slow
milling speed of this serial technique. With focused-ion beam
nanolithography it is also possible to deposit materials. The
desired material to deposit is in the gas phase and it is let to
adsorb on the surface. Afterwards, the ion beam decomposes
the adsorbed molecules into a volatile component and a non-
volatile component. The non-volatile component remains
deposited on the surface. Minimum sizes achieved in deposi-
tion are in the range of few tens of nanometers [67].
A more conventional technique is the electron beam (e-beam)
nanolithography [68]. It uses an electron beam to etch a sub-
strate surface locally or to modify locally a layer of a respon-
sive polymer (e-beam resist) in order to obtain a pattern for
further processing. Like focused-ion beam nanolithography, the
e-beam nanolithography can also deposit materials at the nano-
scale level [68].
Electrospinning is a technique that allows for the fabrication of
a nanofiber-based meshwork. A solution with the desired
polymer is ejected through a capillary towards a substrate by
applying a high-voltage electric field. Long fibers with diame-
ters in the range from 2 nm to several micrometers can be
generated [69-72]. However, electrospinning has not been yet
satisfactorily employed to obtain nanofibers from natural pro-
teins such as fibronectin. Recently, an alternative method has
been developed where nanofibers of extruded fibronectin
through a nanoporous aluminum oxide membrane were
obtained. This method is based on a mechanical force to
provoke fibrillogenesis (generation of fibers) of fibronectin
[78].
Nanoskiving is a less conventional technique for the fabrication
of nanostructures, where basically a thin metal film is embed-
ded between two epoxy layers. One of the epoxy layers contains
a nano- or micropattern on which the metal layer is deposited
(e.g., through vapor deposition). Then, a second epoxy block is
cured on top of the deposited metal layer and the molding of
this second epoxy layer represents the underlying nanostructure.
Thus, thin sections (ca. 30 nm) can be obtained by ultramicro-
tomy, which are then transferred to a silicon substrate used as a
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master to mold silicon on top. Finally, by treating the
epoxy–silicon sandwich with oxygen plasma the epoxy is elimi-
nated, rendering the metal structure on the silicon substrate
[46,73].
Colloidal lithography is a technique relying on the arrangement
of colloid particles, on 2D or 3D surfaces, to use it as masks for
subsequent etching or sputtering processes. It is a low-cost tech-
nique that does not require complex equipment since the pattern
can be obtained by spin-coating the surface or by dipping it in
the colloidal solution. Moreover, this technique allows for large
surface patterning. The size of the colloids is tunable and deter-
mines the resolution of the pattern. Resolutions of few tens of
nanometers can be achieved [74,75].
1.4 Materials selection
The importance of choosing the appropriate material for
cell–substrate interaction studies depends on the inherent ability
of the material to be modified in its surface chemistry since bio-
logical cell adhesion via integrins or other adhesion molecules
will generally not directly occur to inorganic or organic poly-
meric materials. Thus, further modification of the surface with
adhesive molecules, for example with proteins from the extra
cellular matrix is required. Additionally, it may be desirable to
tune the mechanical stiffness of the material since recent
advances in cellular mechanobiology have demonstrated the
drastic effect of material compliance on various cell functions
[79-82]. Moreover, the material of choice should also be suit-
able for the fabrication method used to generate micro- and
nanoscale topographies. To be compliant with cell experiments
the materials have to be implicitly non-cytotoxic in in vitro cell
studies, or should be biocompatible for (future) in vivo applica-
tions [3,4,48,83-86].
There is a wide variety of materials including polymers, silicon,
metals, ceramics, and composites made from various combina-
tions of such materials [3,48,85,86]. Due to the vast amount of
literature on different materials, only the most relevant materi-
als used in studies with vascular cells are described below. Ad-
ditional examples for materials are listed in Table 1 and in some
other review articles [4,5,46,47,71,86,87]
Polymers from natural sources can be divided in either protein-
based (e.g., collagen, fibrin, matrigel, elastin), polysaccharide-
based (e.g., hyaluronic acid, chitin, agar, dextran, alginate)
polymers, rubbers (e.g., cis-poly(isoprene), or polyesters (e.g.,
polyhydroxyalkanoates) [88-97]. Although they are typically
non-cytotoxic and biocompatible, it is often very challenging to
use them for most microfabrication processes. Independently of
their use as pure or as combined polymeric materials, they
frequently lack a clearly defined architecture, and they have a
variable chemical composition and often complex mechanical
properties. These disadvantages and difficulties in using natural
polymers for the fabrication of cell culture substrates strongly
motivated the development of alternative synthetic substrates
[4,86,87,98-100]. Polymeric synthetic materials are the broadest
and most diverse class of biomaterials available for cell research
[89]. Some of these materials enable a good control of their sur-
face chemistry, mechanical properties and geometry. Moreover,
their non-cytotoxicity, their ease to use with many fabrication
techniques and often the simplicity of their synthesis makes
them to be widely used within the field of biomaterials
[4,5,55,85,99-102]. Examples of the most representative synthe-
tic polymeric materials used for vascular cell studies are
poly(dimethylsiloxane) (PDMS) [6,61,103-106], poly(ethylene
glycol) (PEG)-derived polymers [5,87,98,107-113] poly(acryl-
amide) (PAA) [50,114-116] and poly(lactic acid) (PLA)
[117,118]. Alternative materials used for micro- and nanostruc-
turing are glass [119], ceramics [119-122] or natural polymers
that can also be synthetically modified by, e.g., functionalizing
with an artificial polymeric group [113,123]. Coating of
these materials with silicon carbide, expanded polytetrafluoro-
ethylene, tantalum, and hyaluronan has also been applied [124-
127].
Apart from substrate topography, cells also respond to mechani-
cal properties of the substrate and to the surface chemistry.
Therefore, it is of importance to control these properties in
order to precisely study, modulate or predict cell behavior. In
the following section, a brief summary of the most common
methods for control of the surface biochemistry and of the me-
chanical properties of the substrate are given.
1.5 Surface (bio)functionalization
The surface (bio)chemistry of a material may regulate cell adhe-
sion, survival, proliferation and differentiation of vascular cells
or progenitor cells [10,31,126,128-131]. In order to make a bio-
logical meaningful contact with a surface, cellular trans-mem-
brane adhesion molecules such as integrins need to interact with
specific counterparts, generally ligand molecules of the extra-
cellular matrix or molecules with similar motifs [132-136]. The
interaction between cell-surface receptors and the substrate can
be specific, where a cell ligand on the substrate specifically
interacts with a cell receptor, or unspecific, where cell recep-
tors interact unspecifically with the substrate due to electro-
static interactions. The sum of these ligand–receptor interac-
tions, basically the biological adhesion, is signaling
outside–inside and is a key factor for regulation of cell func-
tions [137,138]. Therefore, adequate and controlled (bio)func-
tionalizing of a materials surface is desired to have a predictable
influence on cell behavior. Moreover, some synthetic materials
are not promoting cell adhesion; a functionalization of the sur-
Beilstein J. Nanotechnol. 2016, 7, 1620–1641.
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face prior of cell contact becomes necessary to render it cell-
adhesive.
There are numerous methods and strategies for chemical sur-
face functionalization. It will be beyond the scope of this review
to give a detailed account; only a few examples can be depicted.
One simple and often used way to functionalize a surface non-
specifically with molecules is by simple physisorption, often
after enhancing the surface charge of hardly adhesive surfaces
[139]. The latter is typically achieved by oxidizing the surface.
Surface oxidation can be performed by means of oxygen plasma
treatment, ultra violet (UV) light (for polymers) or chemical
treatment [140-144]. Physisorption of molecules is typically an
easy method for coating a surface more or less homogenously
[139]. Apart from its simplicity, there is limited control and
predictability about the number of adsorbed molecules, their
orientation and three-dimensional configuration, and thus, their
biological functionality. The sometimes relatively weak adhe-
sion strength of the molecules is disadvantegous too. Using
more advanced chemistry for immobilizing the molecules of
interest in a controlled fashion [145-148].
Typical molecules used for non-specific surface coatings are
poly-L-Lysine (PLL) and poly(lactic acid) (PLA), both interact
unspecifically with cells through electrostatic interactions
[149,150]. A more native coating of artificial surfaces can be
achieved by absorbing molecules from the extracellular matrix
(ECM). Commonly used cell ligands enabling a specific cell
adhesion are either the full molecules or peptides with motifs
from ECM molecules such as fibronectin, laminin, collagen and
vitronectin [151-154]. One has to keep in mind, that in most in
vitro and particularly in in vivo environments plenty of differ-
ent proteins are getting in contact with the surface and alter the
initial coating, thus making it difficult to maintain defined
coating over longer time periods.
Control of the spatial distribution and density of molecules is
for many biological investigations an interesting option. Such
patterning with adhesive molecules can be realized by several
techniques. Commonly used are microcontact printing [53,155]
dry lift-off [58,156], dip-pen nanolithography [157,158], and
block copolymer micelle nanolithography [159]. All these
methods are just exemplary techniques allowing the (bio)chemi-
cal modification of structured surfaces for in vitro cell studies.
Despite the precision of the modification that many of these
methods achieve, it is important to keep in mind that in contact
with a biological environment (e.g., cell culture media contain-
ing serum) there is an abundance of additional molecules, which
may get absorbed to the surface of the substrate in an uncon-
trolled fashion. Additionally, cells can actively modify the
surface biochemistry, for example by secreting ECM molecules
or by rearranging the structure of the molecules attached
to the surface, thus altering the initial surface chemistry
drastically.
1.6 Mechanical properties of micro- and
nanostructured substrates
Cells can respond to changes in the mechanical properties of a
substrate. Depending on the tissue in which cells live, the stiff-
ness of the ECM can strongly vary from very low stiffness (e.g.,
brain: ca. 0.1–3 kPa) to intermediate stiffness (e.g., muscle: ca.
8–17 kPa) to high stiffness (e.g., cartilage: ca. 25–40 kPa) even
reaching values in the order of megapascals or gigapascals, e.g.,
in bones [48,79,85-87,160]. In order to imitate in vitro the me-
chanical properties of the natural ECM, different materials are
available that can be tuned in their mechanical properties. The
most relevant and commonly used materials for this purpose are
poly(ethyleneglycol) diacrylate (PEG-DA) or other PEG-
derived polymers [5,87,98,107-113], poly(acrylamide) (PAA)
[50,114-116], and poly(dimethylsiloxane) (PDMS) [6,61,103-
106]. They are all not cytotoxic, relatively easy to handle, cheap
to produce and their stiffness can be tuned over a wide range
(from few tens of pascals to mega- or gigapascals). PEG-DA
hydrogels consists of a polymer of ethylene glycol diacrylate
monomers [48,161]. By varying the length of the polymer and
its ratio with a crosslinker molecule the pore size of the
hydrogel and thus its stiffness can be varied. Their elasticity can
be tuned over a wide range from below 1 kPa to above 100 MPa
[79]. An additional feature of PEG hydrogels is their low pro-
tein absorption. This characteristic makes them often to the
coating material of choice when surfaces need to have low pro-
tein absorption [36,162,163]. Commonly used in cell culture ex-
periments are PAA hydrogels [50,114-116]. They are made of
acrylamide (the monomer), bis(acrylamide) (the crosslinker
molecule) and a photoinitiator, which triggers polymerization.
By varying the ratio between monomer, crosslinker and
photoinitiator, as well as the intensity of UV light and the expo-
sure time, the pore size of the hydrogel and consequently the
elasticity can be tuned. Stiffness from PAA hydrogels can be
tuned from ca. 50 Pa to more than 700 kPa [50,114-116]. Due
to their easy availability and handling, PAA gels have found
frequent application in cell mechanics studies [50,114-
116,164,165]. PDMS is an elastomeric material [6,61,103-106].
Unlike PEG and PAA, PDMS is not a hydrogel but a hydro-
phobic polymer. Variation in hydrogel stiffness changes usually
the meshwork properties and water content of the gel [114]. In
the elastomer polymer, only the cross-linking density is varied.
The stiffness of PDMS is modified by altering the ratio be-
tween monomer and curing agent, curing temperature, and
curing time [114,115,166]. The Young’s modulus of PDMS can
vary from 0.1 kPa [114] to a few megapascals [166]. All these
three artificial polymeric materials are by themselves non-
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adhesive for cells. Therefore, surface functionalization with cell
adhesive molecules is essential prior to cell culture studies.
In summary, the engineering of defined micro- and nanostruc-
tured cell culture substrates covers a whole range of different
fabrication techniques and various materials. Generally, the fab-
rication methods applied to structure the surface of a (bulk) ma-
terial limit the choice of materials (since not all materials are
compatible with all fabrication techniques).
2 The vascular cell system and the
responses of vascular cells to surface
topographies in the micro- and nanometer
range
The vascular system is one of the key systems of the human
body and sustains normal human physiology during develop-
ment, human life span and response to injuries [130]. Blood
vessels are built from and regulated by an inner layer of
vascular endothelial cells (ECs), and an outer layer of vascular
smooth muscle cells (SMCs) (Figure 2) [167,168]. ECs are
lining the inner part of the blood vessel (tunica intima), forming
the so-called endothelium, and therefore they are in contact with
the blood stream. Normally, ECs orient themselves to the direc-
tion of the blood stream. The endothelium acts as a barrier be-
tween the lumen of the vessel and the surrounding tissue, medi-
ating for example leukocyte extravasation. It also plays a role in
blood clotting and angiogenesis (formation of new vessels). On
the other hand, SMCs are found in an outer layer surrounding
the endothelium (tunica media). These cells are responsible for
regulating the blood pressure by contracting or dilating. SMC
contractility is chemically regulated by nerve cells and by ECs.
The two vascular cell types are key players in vascular disease
such as stroke, heart attack, and vascular occlusions [169,170].
A complete understanding of vascular cell biology requires a
systematic, structural and separate analysis of the multiple inter-
dependent signaling pathways in the cells types, the surround-
ing tissue and the blood [171-176]. Thereby, a multitude of
stimulating signals, such as messenger molecules, ECM,
pulsatile blood flow and endogenous electrical fields exist in
and around the vasculature [177-179]. Additionally, in blood
vessels of healthy humans, the regulation of SMC proliferation
and migration is normally rigidly regulated by the endothelium
formed by ECs [180].
Some important biological processes in vivo are mediated by
signals that the features of the surface provide to adhering cells.
For example, neuronal axons are guided by aligned Schwann
cells, which at the same time are thought to be oriented by the
ECM [181,182]. Recently, it has been demonstrated in mice that
Schwann cells are guided by blood vessels [183]. In wound
healing, another important biological process, cells are guided
by the ECM to migrate towards the affected area for regenera-
tion and healing [184].
To date, many studies have been carried out in vitro in order to
elucidate the role of material properties in complex biological
processes. It is known that micro- and nanoscale topographies
of a substrate can influence cell adhesion, morphology, prolifer-
ation rate, migration velocity and directionality, gene expres-
sion, stem cell differentiation and even the epigenetic state of a
cell (Figure 5) [10,12,79,185-197]. In vivo, the ECM where
ECs and SMCs attach to, provide them micro- and nanotopo-
graphical stimuli to regulate their behavior [58]. Therefore, the
in vitro investigation of cell type-specific functions and
responses with vascular cells to surface topographies, either in
the micrometer or in the nanometer range, provide new solu-
tions to control the behavior of such cells and has already
attained much interest [3,5,12,23,24,30,31,45,198]. Recent
research has tried to elucidate mechanisms by which the inde-
pendent stimulation of endothelial (ECs) and smooth muscle
cells (SMCs) may be achieved by introducing surface topogra-
phies [8-12,199,200]. One of the main interests of these studies
are the micro- and nanostructuring of medical implants for the
in vivo control and stimulation of (vascular) cells behavior
[8-10,12,201,202]. For example, it has been demonstrated that
an efficient approach to improve the functions of a medical
stent is the application of a morphological texture to the stent
surface (topography), which controls and regulates the behav-
ior of vascular cells [126,203]. Generally, the investigations of
the cellular behavior upon culturing cells on structured surfaces
have been performed with vascular cells from different species
such as human, mouse, rat, and bovine and from different
organs, for example, aorta, umbilical vein, bladder, and lung
[5,16,21,23-25,204,205]. For a systematic overview of the
information presented in the following sub-sections refer to
Table 1.
2.1 Survival and proliferation rate of vascular cells
are influenced by surface topography
Live/dead staining is the most used assay to determine cell
survival on a particular substrate and hence the cytotoxicity of a
material is assessed [14,209]. Besides this live/dead cell investi-
gation, biochemical proliferation assays, such as EdU or BrdU
staining, are frequently applied to determine the cell division
rates [26,204,205,210,211]. Often, the proliferation behavior of
cells is simply evaluated by counting the number of cells and
comparison of the actual number with the number of initially
seeded cells [26,204,205,210,211].
SMCs: Proliferation of SMCs is differently regulated
depending on the feature geometry and size. Some studies re-
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Figure 5: Endothelial and smooth muscle cells on surface topographies with different sizes (at the micro- and nanoscale) and geometries react by
changing their adhesion strength, their proliferation rate, their genetic expression, by adapting their morphology, by migrating directionally, by
changing their migration speed, or by inducing stem cell differentiation or cell reprogramming. Double arrow pointing up and down means that
depending on the study or experimental conditions that parameter increases or decreases. The SEM image “Nanowires” has been reproduced with
permission from [206], copyright 2014 the authors. SEM micrograph “Micropillars” has been reproduced with permission from [207], copyright 2015
Elsevier. The SEM image “Micropores” has been reproduced with permission from [208], copyright 2014 Elsevier.
ported that proliferation of SMCs was negatively affected by
PDMS microgrooves [204,205] and titanium oxide (TiO2)
nanotube surfaces [31]. However, nanopits positively regulated
SMC proliferation and gene expression [30]. In other studies,
human SMCs from the vascular system and bladder, showed an
increased proliferation rates on a poly(glycolic acid) (PGA)
mesh, as well as on poly(ether urethane) (PU) and poly(lactic-
co-glycolic acid) (PLGA) substrates with nanoroughness
[41,42,44].
ECs: Similar to SMCs, the regulation of ECs proliferation
depends also on the shape and size of topography. The prolifer-
ation rate of ECs has been reported to increase on metals (Ni, Ti
and Co) and polymer substrates (PLGA and PCL) with nanor-
oughness present on the surface compared to the EC prolifera-
tion rate on flat surfaces [10,29,31,45]. Nevertheless, the prolif-
eration rate of ECs on colloidal silica-coated surfaces with
nanoroughness was decreased compared to ECs on flat
surfaces [43].
For both types of vascular cells it is not clear through which
mechanism the cell proliferation is influenced by the surface to-
pography. Therefore, more research has still to be performed in
these cell types to determine how substrate shape and feature
dimensions correlate with cell proliferation.
2.2 Structured surfaces influence the morphology,
adhesion, and motility of vascular cells
Cells cultured on micro- and nanostructured substrates tend to
change their morphology and their adhesion behavior/machin-
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ery according to the substrate topography (surface shape and
size) as well as they frequently adapt their motility (Figure 4C)
[5,13,209,212-215].
ECs: Previous studies showed a dependence of the strength of
endothelial cell adhesion on the surface structure and its size.
For example, ECs on nanoislands with low height (13 or 18 nm)
showed an increased adhesion and spreading. However, on
higher nanoislands (27 nm and above), the adhesion and
spreading of ECs were reduced compared to those on flat
surfaces [38-40]. In another study, ECs cultured on PEG
nanopost structures showed stronger adhesion compared to
those cultured on flat PEG substrate [36]. A different work
demonstrated that ECs on silicon nanoposts, revealed stronger
adhesion and spreading in comparison to ECs on flat silicon
surfaces [210]. It has also been reported that the nanoroughness
of metal (Ni, Ti and Co) and polymer (PLGA and PCL) sur-
faces improved EC adhesion compared to flat surfaces
[10,29,31,45]. It is possible that the increase in EC adhesion is
due to an increase in ECM protein adsorption and/or change of
cell adhesions sites of these proteins probably caused by the
increase of boundaries and surface energy on the surface
[10,36].
Many cells show directed migration and a polarized morpholo-
gy on nano- and microstructured substrates. The process by
which cells orient and migrate along the longest axis of a sur-
face feature is called contact guidance [186,216]. Many cell
types on different surface topographies of various dimensions
have been observed to experience contact guidance [217-222].
The most commonly used surface structure to study this phe-
nomenon consists of arrays of ridges and grooves. Generally,
cells orient preferably stronger along the direction of grooves
and ridges, the narrower and deeper/higher these structures are
[5,12,156,192,221-225]. It was observed that few tenths of
nanometers in structure depth was already sufficient for some
cell types to trigger contact guidance [201,202]. The limit of
cell sensing, by filopodia, so far has been reported to be
10 nm-high nano-islands [226]. Furthermore, cell alignment to
the direction of grooves was predicted with an automatic
controller model [227]. This model concluded that cell align-
ment along the direction of grooves is proportional to the square
of the aspect ratio (depth to width ratio) of the grooves/ridges
[227]. As follows, some examples of morphological adaptation
of vascular cells on substrate topographies are explained. For an
extensive summary and literature review of vascular cell reac-
tions to topography see Table 1.
SMCs: SMCs revealed on microgrooved PDMS substrates an
enhanced aspect ratio (cell length to width ratio) and a parallel
alignment of the cell body with respect to the groove axis
(Figure 4C) [21,24]. Rat-derived SMCs aligned stronger along
the direction of microgrooves, the narrower these grooves were
[21]. Moreover, cells also change other morphological parame-
ters, such as cell area or elongation, depending on surface struc-
ture shape and size [228]. For example, the elongation of SMCs
was enhanced by the groove structure [204]. However, a struc-
ture composed of nanopits demonstrated no significant influ-
ence on SMC morphology [30].
ECs and SMCs: A similar effect was observed for SMCs, as
well as ECs, cultured on nanogrooved structures, where the
cells aligned and migrated in parallel with respect to the groove
axis [15,25,204,229]. Internal cell structures important for to-
pography detection and for conferring cell shape (i.e., focal
adhesions (FAs) that are complexes of proteins anchoring to the
substrate and regulating cell adhesion strength, and actin
cytoskeleton) have been observed to change and adapt to sur-
face topography. Probably the influence of the topography on
these internal structures provokes the morphological change of
the cells [204,215]. These morphological adaptations of the
cells to surface structures were shown to be cell-type dependent
[12]. This observation is important to consider in the design of
cell type-specific medical implants since topographical cues of
an implant could specifically and differently instruct cell reac-
tion [12]. In addition to the tendency that cells orient their body
along microstructures, cells also prefer to migrate along the
longest axis of the structures present on the surface (Figure 6)
[230,231]. In different studies, both SMCs and ECs, were ob-
served to migrate directed along the groove direction
[12,13,204,214,232,233]. It has been reported for some cell
types that their migration velocity on microstructured surfaces
increased compared to flat surfaces [212,234-237]. Neverthe-
less, there is still no clear consensus about the effect of surface
topography on SMCs and ECs migrat ion veloci ty
[32,214,232,233,238]. A possible explanation to the differences
in migration velocity on topographies would be the dynamicity
of FAs. Dynamic FAs of ECs were correlated with a higher
migration velocity than more stable FAs [213]. Moreover, the
FA size was correlated with migration velocity. Generally, the
bigger the FAs are, the faster cells migrate [239]. A different
study found a correlation between cell stiffness and SMCs
migration velocity. When cell stiffness increased, migration
velocity decreased and vice versa. The increase of cell stiffness
correlated with the increase in F-actin (filamentous actin) and
vinculin (a protein from FAs) [240]. Nevertheless, systematic
studies correlating the topography shape and size with vascular
cell migration velocity need to be performed. Additionally, the
cell mechanisms enabling directed migration to surface topogra-
phy and influencing on migration velocity have still to be eluci-
dated. These factors could have a great potential for the design
of, e.g., stents [241].
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Figure 6: Human vascular smooth muscle cells (SMCs) cultured on a micrometer-sized grooved surface made of poly(dimethylsiloxane) (10 µm
groove width; 650 nm groove depth). The exemplary images show the cell guidance reaction of the SMCs in a wound healing experiment. After
7 h 30 min the SMCs migrated preferentially along the direction of the micrometer-sized grooves.
2.3 The cytoskeleton and cell-matrix adhesions of
vascular cells cultured on micro/nanostructured sur-
faces
It is necessary to understand the signal pathways that transduce
external physical stimuli into internal biological responses. The
transduction of ECM surface topography information requires
many intracellular mechano-sensitive elements and processes
that finally lead to a cellular reaction (Figure 1 and Figure 2c)
[173,175,242,243]. Often the signaling of several different
mechano-sensors is combined and finally summed up. Thus, to
be able to control cell adhesion and alignment in a cell-specific
manner it is important to ask how a cell senses surface topogra-
phy. The ECM physical signals can be transmitted through focal
adhesions and the cytoskeleton system often by a signaling
cascade initiated by integrin receptor activation [172,244-247].
Thus, one possible and likely scenario is the detection of the
surface topography by cytoskeleton elements (in particular
actin) and focal adhesions, and the probing of the topography
by protrusions and filopodia (Figure 1 and Figure 2c) [226,248-
250]. Thus, some studies analyzed intracellular structures such
as the cytoskeleton and cell–substrate adhesion sites of cells
cultured on nano/microstructured substrates in detail
[13,15,20,213,215,251,252]. For example, the reorganization of
the actin cytoskeleton has been observed in experiments where
cells were placed on small ECM islands and then showed
limited spreading [247].
SMCs: SMCs showed on microgrooved PDMS substrates a
parallel alignment of actin filaments with respect to the groove
axis [21,45]. In another study, focal adhesions of the same cell
type grown on microgrooved substrates were more mature
along the grooves, hence more tension was most likely created
and cells aligned parallel being thus guided by microtopog-
raphy [15]. In contrast to this work, some other studies claim
that focal adhesions and actin stress fibers development are not
necessary for contact guidance to take place [217,218]. In dif-
ferent studies, both human vascular and bladder SMCs,
increased FAs size on a PGA mesh, and PU or PLGA nanor-
oughness substrates [41,42,44]. However, it is still not known if
actin filaments are already polymerized along grooves or if their
orientation is due to preferential actin contraction along
grooves.
ECs: It was reported that the focal adhesion area from endothe-
lial cells was increased on microgrooved substrate (groove
dimensions: 1 µm depth, width) compared to the area of focal
adhesions of cell cultured on flat substrate or shallower grooves
[20]. Protein unfolding or conformation change at the bound-
aries between grooves and ridges, could facilitate FA formation
and increase of its size [253].
SMCs and ECs: In an additional report, the spreading proper-
ties and focal adhesion system of EC and SMCs on nanopat-
terned ECM-mimicking surfaces was evaluated [251]. For this,
the authors applied an array of biofunctionalized gold nano-
structures. The gold nanoparticles on these surfaces have a di-
ameter of 8 nm and had interparticle spacings of 40 nm or
90 nm and were conjugated with a RGD-peptide or a REDV
peptide (R: arginine; G: glycine; E: glutamic acid; D: aspartic
acid; V: valine) or with vascular endothelial cadherin (VE-
cadherin) [251]. Non-functionalized surfaces or surfaces with
spacing larger than 73 nm failed to induce the formation of FAs
and actin stress fibers [251,254]. The universal distance-depen-
dence for focal contact formation and cell adhesion shown pre-
viously for other cell types (e.g., MC3T3-osteoblasts, REF52-fi-
broblasts, 3T3-fibroblasts, and B16-melanocytes [251]) hold
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also true for the two vascular cell types (ECs and SMCs) inves-
tigated [255]. A distance-dependent behavior for ECs and
SMCs on VE-cadherin decorated nanopatterns was also demon-
strated here. Although both cell types adhere equally poor on
VE-cadherin compared to the RGD and REDV peptides, a
universally characteristic cell adhesion behavior depending on
the ligand spacing was indicated [255].
2.4 Signal transduction pathways and cell nuclei
morphology of vascular cells cultivated on
micro/nanostructured substrates
It has been observed in other studies, that the activation of many
membrane proteins such as ion channels, membrane-associated
G proteins coupled receptors (GPCR), and receptor tyrosine
kinases (RTK) are related to ECM physical stimuli [256-264].
Surface topography also induces the activation of intracellular
signaling molecules such as Rho GTPase, mitogen-activated
protein kinases (MAPK), extracellular signal-regulated kinases
(ERK), and Jun N-terminal kinase (JNK) [265-268]. Overall,
mechano-transduction finally often leads to the activation of
specific nuclear transcription factors, like the early growth
response (Egr-1), the nuclear factor NFκB, and the activator
protein (AP-1) [265-268].
SMCs: In case of SMCs, nanopits structures regulated their
gene expression [197]. On titanium oxide (TiO2) nanotube sur-
faces, vascular SMCs expressed more SMC α-actin (a marker of
differentiation) [129].
YAP/TAZ (Yes-associated protein/transcriptional coactivator
with PDZ-binding motif) is a protein complex that induces the
expression of proliferative genes. YAP/TAZ acts as a mechani-
cal checkpoint and is not only regulated by the Hippo pathway
but also by the reorganization of the actin cytoskeleton
[247,269,270].
ECs: It has been demonstrated that ECs cultured on small areas
coated with ECM protein (below 300 µm2) showed a weak
actin stress fibers network (less actin bundles) and a switch of
the YAP/TAZ localization from the nucleus to the cytoplasm
compared to the fully spread cells [269]. A similar effect has
also been observed for ECs growing on soft ECM substrate (ca.
0.7 kPa), where the actin cytoskeleton was weakened and the
nuclear localization of YAP/TAZ was reduced, compared to the
cells culture on a fibronectin-coated glass surface. The protein
Rho and the formation of actin stress fibers, but not actin poly-
merization alone, were required to increase YAP/TAZ nuclear
localization [269].
Nuclei also tend to adapt their morphology directly to surface
microtopography in a similar manner as cell bodies adapt
[17,271]. However, in some cases the orientation of nuclei
differs to that of the cell body [211,272-275].
SMCs: SMCs showed on microgrooved PDMS substrates a
parallel alignment of cell nuclei with respect to the groove axis
[21,24].
The fact that the nuclear shape is influenced by microstructures
leads to the assumption that some changes in the genetic materi-
al could take place. It was revealed that changes in nuclear
shape, non-invasively induced by microgrooves, caused reorga-
nization of nuclear lamina and chromosomes repositioning
[276]. Some different gene regulations were attributed to these
changes in chromosomes positions [276]. In a different work, a
dramatic drop of SMC proliferation on micropillars was re-
ported and was argued that the deformation of the nuclear lamin
was responsible of this change in proliferation rate [277].
ECs: Differently regulated genes from cells on microstructures,
in comparison to cells on flat surfaces, showed that endothelial
cells on microgrooves down-regulated genes related to the cell
cycle as well as their gene for β1 integrin [278].
In the future, it would be interesting to study the influence of
nucleus morphology in vascular cells gene expression and the
role of mechanotransduction mechanisms involving gene regu-
lation. Moreover, a study correlating actin-mediated cell
tension, with nuclei deformation and genetic expression
changes would be of interest, since it was previously found a
relation between actin-mediated cell stiffness and nucleus de-
formation [279].
Conclusion
In this review article, we have presented the state of the art of
the most commonly used materials and methods to micro- and
nanostructure surfaces for vascular cell investigations. More-
over, vascular cell responses to these topographical stimuli were
also presented and discussed. Although many studies, with both
cell types (ECs and SMCs), have shown the influence of materi-
al, geometry and size of topographical features, on cell mor-
phology, migration, and proliferation, there is not yet a correla-
tion between different geometries and sizes of topography and
cell response. For example, there is no clear consensus between
structure dimensions and migration speed for both vascular
cells.
In order to better understand how these cell responses change
depending on the surface topography, the main internal struc-
tures playing a role in cell mechanotransduction (focal adhe-
sions and actin cytoskeleton) have been studied. FAs and actin
cytoskeleton were commonly observed in many studies to orient
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along structures as cells do. Although some studies correlated
differences in FA size and dynamicity with cell migration
speed, further research has still to be done in order to broaden
the observation. Another important aspect that it should be
addressed in future research is how FAs and actin cytoskeleton
are influenced by the topography.
To further deepen in the understanding of vascular cell behav-
ior on topographies, studies have been performed to analyze
gene and protein expression. Changes in genetic expression at-
tributed to a morphological change in cell nucleus have been
shown. However, the relation between shape of the nucleus and
gene expression levels is still not known yet. In fact, the protein
complex YAP/TAZ, was observed to regulate cell proliferation
on ECs seeded on substrates of different stiffness. Since the
actin cytoskeleton is responsible of reducing cell proliferation
through YAP/TAZ phosphorylation, it would be interesting to
investigate if surface topography affects YAP/TAZ activation
through changes in the actin cytoskeleton.
Although a lot of investigations on vascular cells reactions to
surface topographies are still to be done, this research will even-
tually lead to a better understanding of important biological pro-
cesses (e.g., tissue regeneration) and to the development of new
medical implants such as stents with modified chemical, me-
chanical and topographical properties. These new medical
implants will enable the in vivo control the behavior of vascular
cells without using, e.g., pharmacological substances.
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